DEPDC5 and fatty liver disease: Unexpectedly, the enlarged liver observed in Depdc5-LKO mice cannot be associated with hepatic steatosis, because Depdc5-LKO mice exhibited even slightly reduced liver triglyceride levels compared to LoxP mice (Fig. 1G).